William Blair Starts Arbutus Biopharma (ABUS) at Outperform
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
William Blair initiated coverage on Arbutus Biopharma (NASDAQ: ABUS) with an Outperform rating.
Shares of Arbutus Biopharma closed at $3.72 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Starts Nutanix (NTNX) at Outperform
- Goldman Sachs Starts Party City (PRTY) at Neutral
- Mizuho Securities Starts Mylan (MYL) at Buy
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesWilliam Blair
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!